Next Article in Journal
Sirtuin 1 and Vascular Function in Healthy Women and Men: A Randomized Clinical Trial Comparing the Effects of Energy Restriction and Resveratrol
Previous Article in Journal
Negative Association between Serum Vitamin D Levels and Depression in a Young Adult US Population: A Cross-Sectional Study of NHANES 2007–2018
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Gene–Diet Interactions on Metabolic Disease-Related Outcomes in Southeast Asian Populations: A Systematic Review

by
Padmini Sekar
1,
Eduard Flores Ventura
1,
Anto Cordelia T. A. Dhanapal
2,
Eddy Seong Guan Cheah
2,
Annaletchumy Loganathan
2,
Phoon Lee Quen
2,
Mahenderan Appukutty
3,4,
Nurpudji Astuti Taslim
5,
Hardinsyah Hardinsyah
6,
Mohd Fairulnizal Md Noh
7,
Julie A Lovegrove
1,
Ian Givens
8 and
Karani Santhanakrishnan Vimaleswaran
1,8,*
1
Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, Institute for Cardiovascular and Metabolic Research (ICMR), University of Reading, Reading RG6 6DZ, UK
2
Centre for Biomedical and Nutrition Research, Universiti Tunku Abdul Rahman, Jalan Universiti, Bandar Barat, Kampar 31900, Malaysia
3
Faculty of Sports Science and Recreation, Universiti Teknologi MARA, Shah Alam 40450, Malaysia
4
Nutrition Society of Malaysia, Jalan PJS 1/48 off Jalan Klang Lama, Petaling Jaya 46150, Malaysia
5
Clinical Nutrition, Faculty of Medicine, Hasanuddin University, Makassar 90245, Indonesia
6
Department of Community Nutrition, Faculty of Human Ecology, IPB University, Bogor 16680, Indonesia
7
Institute for Medical Research, National Institutes of Health, Jalan Setia Murni U13/52, Seksyen U13 Setia Alam, Shah Alam 40170, Malaysia
8
Institute for Food, Nutrition and Health (IFNH), University of Reading, Reading RG6 6AH, UK
*
Author to whom correspondence should be addressed.
Nutrients 2023, 15(13), 2948; https://doi.org/10.3390/nu15132948
Submission received: 30 May 2023 / Revised: 16 June 2023 / Accepted: 21 June 2023 / Published: 29 June 2023
(This article belongs to the Section Nutrigenetics and Nutrigenomics)

Abstract

:
Diabetes and obesity are chronic diseases that are a burden to low- and middle-income countries. We conducted this systematic review to understand gene–diet interactions affecting the Southeast Asian population’s risk of obesity and diabetes. The literature search was performed on Google Scholar and MEDLINE (PubMed) search engines independently by four reviewers who evaluated the eligibility of articles based on inclusion criteria. Out of 19,031 articles, 20 articles examining gene–diet interactions on obesity and/or diabetes-related traits met the inclusion criteria. Three (Malaysia, Indonesia, and Singapore) out of eleven Association of Southeast Asian Nations (ASEAN) countries have conducted studies on gene–diet interactions on obesity and diabetes. From the 20 selected articles, the most common interactions were observed between macronutrients and genetic risk score (GRS) on metabolic disease-related traits in the Malay, Chinese, and Indian ethnicities. Overall, we identified 29 significant gene–diet interactions in the Southeast Asian population. The results of this systematic review demonstrate ethnic-specific gene–nutrient interactions on metabolic-disease-related traits in the Southeast Asian population. This is the first systematic review to explore gene–diet interactions on obesity and diabetes in the Southeast Asian population and further research using larger sample sizes is required for better understanding and framing nutrigenetic approaches for personalized nutrition.

1. Introduction

Metabolic diseases such as obesity and diabetes are now considered epidemics rapidly spreading across developed and developing countries affecting both sexes, age, ethnicities, and socioeconomic groups [1]. This, in turn, has shown to compromise the quality of life that leads to potentially life-threatening conditions such as cancers, cardiovascular diseases, musculoskeletal disorders, and hypertension [2]. According to the 2021 reports from the World Health Organisation (WHO), worldwide obesity has tripled since 1975, with over 650 million obese adults and more than 340 million children and adolescents who are either overweight or obese [3]. By 2022, diabetes reports from WHO indicate that more than 422 million people are diabetic with rising prevalence in low-middle income group countries (LMIC) compared to developed countries [4]. Projected trends also show that diabetes and obesity are rapidly growing and will affect nearly two-thirds of the Southeast (SE) Asian population by the end of 2030, placing a burden on rural and low socioeconomic groups [5,6]. Recent reports from the Association of Southeast Asian Nations (ASEAN) show that the tripling rate of undernutrition has not improved and that obesity and diabetes are now a double burden for these countries [7,8].
Understanding gene–nutrient interactions provide insights regarding nutritional, genetic, and biochemical determinants to better understand complex interactions between environmental factors (including diet) and genes relevant to metabolic health and dis-eases [9,10]. Several studies have also reported the importance of physical activity and nutrient intake which potentially interact with genetic predispositions of a disease that promote the progression and pathogenesis of metabolic diseases [11]. Many studies have also reported the influence of certain gene–diet interactions on metabolic disease-related traits and emphasized the importance of a healthy lifestyle that may modify the outcome of the disease or its related parameters [10,11,12,13,14,15]. A better comprehension of the relationship between genes and diet is key to making correlations between nutrition and wellness, thereby allowing for specific nutritional suggestions that are tailored to individuals or genetic subgroups. This strategy presents an appropriate public health approach [9].
The increasing prevalence of diabetes and obesity in SE Asia can be understood by the nutrition transition phenomenon, environment multiplier theory, and the thrifty gene hypothesis [16,17]. These theories provide an understanding of the dietary shift from traditional high-carbohydrate, low-fat diets towards high-energy diets (high saturated fat, sugars, and salt), and the role of inherited genetic predispositions in over-nutrition-related diseases. Dietary factors can affect the outcome of a disease and there are ethnic-specific genetic variations that influence the mechanism of these nutrient interactions [2]. Furthermore, lifestyle/dietary factors could influence genetic predispositions of metabolic disorders, especially obesity, and diabetes [18,19,20,21], making nutrigenetics research a necessity in ethnically diverse populations such as SE Asia. Nutrition science along with a better understanding of nutrigenetics in different ethnic groups is important to improvise personal and societal health [2,20]. This would ultimately add to the efforts of implementing precision nutrition specific to the populations [22,23]. Hence, this systematic review examines gene–diet interactions on metabolic disease-related (diabetes and obesity) outcomes in the 11 SE Asian countries (Brunei, Burma (Myanmar), Cambodia, Timor-Leste, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, and Vietnam) that share sufficient socio-demographic and cultural similarities.

2. Materials and Methods

2.1. Study Identification and Source Strategy

To identify studies involving gene–diet interactions on metabolic disease-related outcomes, a literature search was undertaken until February 2023 using MEDLINE (via PubMed), and Google Scholar search engines (Supplementary Table S1). The reference lists of the included papers and independent search strings used by the researchers were examined until saturation. In PubMed, extensive search was performed using the search string: (polymorphism OR gene OR SNP OR single nucleotide polymorphism OR genetic variation OR genetic variant OR GRS OR genetic risk score OR PRS OR polygenic risk score) AND (“gene–diet interaction” OR “diet-gene interaction” OR SNP-diet interaction OR diet-SNP interaction OR “gene–nutrient interaction” OR “nutrient-gene interaction” OR “gene-lifestyle inter-action” OR “gene-environment interaction”) AND (carbohydrate OR protein OR fat OR fiber OR sugar OR SFA OR saturated fat OR monounsaturated fat OR polyunsaturated fat OR MUFA OR PUFA OR diet OR B12 OR vitamin D OR amino acids OR polyphenols OR egg intake OR caffeine intake OR green tea OR alcohol intake OR meat intake OR energy intake OR food) AND (obesity OR weight OR BMI OR waist circumference OR waist hip ratio OR hip circumference OR adiposity OR metabolic diseases OR body fat OR body composition) AND (Southeast Asia OR Malay* OR Brunei* OR Burm* OR Cambodia* OR Timor* OR Indonesia* OR Laos OR Filipin* OR Philippine* OR Singapore* OR Thai* OR Vietnam*). In Google Scholar, an extensive search was performed using the search string: gene–diet interaction BMI Southeast Asia OR Malay* OR Brunei* OR Burm* OR Cambodia* OR Timor* OR Indonesia* OR Laos OR Filipin* OR Philippine* OR Singapore* OR Thai* OR Vietnam*. The literature search was restricted to studies involving human subjects only.

2.2. Data Extraction

The reviewers (E.V.F., P.S., A.C.T.A.D., and E.S.G.C.) ensured data consistency across the articles extracted for this study, and a narrative synthesis was conducted to compile the data sourced. Duplicate articles were eliminated using EndNote. Titles and abstracts were subjected to blind screening to assess the pre-established inclusion criteria, followed by full-text screening and discussion. The study protocol was submitted to PROSPERO (Identification number: CRD42022366475).

2.3. Study Selection: Inclusion and Exclusion Criteria

Related studies published in PubMed and Google Scholar in the English language were included. Only gene–nutrient interaction (nutrigenetic) studies examining the as-sociation between dietary factors and genes on diabetes and/or obesity-related outcomes were included. Eligible articles on clinical studies, multicentre studies, comparative studies, observational studies, and randomized controlled studies were included. Studies on patients, neonates, children, and pregnant women were included. The study included populations from ASEAN countries namely Brunei, Cambodia, Indonesia, Laos, Malay-sia, Myanmar, the Philippines, Singapore, Thailand, Timor-Leste, and Vietnam. Studies were excluded if they were (1) animal studies; (2) did not include gene–diet interactions; (3) the outcome was not diabetes- and/or obesity-related traits; (4) not examined in the SE Asian population; or (5) nutrigenomic studies (gene expression in response to dietary factors).

2.4. Data Items and Effect Measures

Obesity, diabetes, and parameters associated with anthropometric measurements and attributes were considered primary outputs of data extraction (Table 1 and Table 2). The result of interactions between the exposure (genetic and dietary factors) and outcome (obesity- or diabetes-related traits) was estimated using p-values extracted from the included literature. Based on the statistical output, the interactions were considered significant if the Pinteraction values were below 0.05. In this study, a narrative synthesis was conducted to elaborate on the dietary factors, genetic variation, and disease traits.

2.5. Risk of Bias and Certainty Assessment

The appraisal tool for cross-sectional studies (AXIS) was used to assess the methodological quality and risk of bias (RoB) of the cross-sectional studies (Supplementary Section S1, Tables S2 and S3) [42]. The RoB in non-randomized studies of interventions (ROBINS-1) assessment tool was used for cohort, case–control, and non-randomized studies (Supplementary Section S1, Table S4) [43]. A revised Cochrane RoB tool for randomized trials (Rob2) was used for randomized control trials (Supplementary Section S1, Table S5) [41,44]. This review falls within the framework and guidelines from the synthesis without meta-analysis (SWiM) in systematic reviews [24,26].

3. Results and Discussion

3.1. Nutrigenetics Studies in Southeast Asia

Using PubMed and Google Scholar search engines, we found 19,031 articles matching the search strings. After the full-text screening, we included a total of 20 nutrigenetic studies related to obesity- and diabetes-related parameters carried out in SE Asia. Out of this, 16 studies examined obesity-related outcomes, 13 examined diabetes-related outcomes, and 9 studies observed both obesity, and diabetes-related outcomes. Figure 1 shows the selection of the 20 studies included in this systematic review. From the included studies, only three ASEAN countries (Malaysia, Indonesia, and Singapore) conducted studies to understand gene–diet interactions on metabolic disease-related traits.

3.2. Gene–Diet Interactions on Obesity-Related Outcomes in the Southeast Asian Population

Gene–diet interactions on obesity-related traits were observed in five Malaysian, seven Indonesian, and four Singaporean studies (Figure 2, Table 1).

3.2.1. Malaysia

The interaction between gene variants and dietary factors on obesity-related outcomes were examined in five Malaysian studies: four cross-sectional ([24,25,27,28]) and one randomized control trial (RCT) [26].
One cross-sectional study (n = 200) in Chinese and Indian ethnic groups living in Malaysia reported no significant interaction between FADS1 SNP rs174547 and linoleic acid (LA) or α-linolenic acid (ALA) on WC but showed that vegetarians with TT genotype of FADS1 gene had higher odds of metabolic diseases and larger WC [24]. The FADS1 gene is involved in the lipid metabolic pathway to catalyze the biosynthesis of unsaturated fatty acids and is known to play a significant role in the maintenance of triglycerol and HDL-c levels [45].
Another cross-sectional study in 217 individuals showed significant interaction (Pinteraction = 0.018) between maternal vitamin D deficiency and cord VDR SNP rs2228570 on neonatal birth weight and an inverse association of maternal vitamin D deficiency with neonatal birth weight indicating the importance of this gene–diet interaction on fetal anthropometry [25]. Vitamin D is a secosteroid and a prohormone that plays a pivotal role in embryogenesis, calcium homeostasis, and fetal bone development and its deficiency is associated with adverse fetal and maternal outcomes [46]. This explains the importance of understanding maternal vitamin D status along with a genetic factor, here cord VDR SNP rs2228570, to examine how gene–nutrient interaction can influence neonatal birth anthropometric outcomes.
The third cross-sectional study (n = 507) in the Malay, Chinese, and Indian ethnic groups analyzed the interactions between AGTR1 and AGTR2 gene variants and different dietary patterns on body mass index (BMI). This study revealed no significant interactions between AGTR1 SNP rs5186 and the dietary patterns (vegetables, fruits, soy diet (VFSD) in Malays and rice, egg, and fish diet (REFD) in Chinese) on BMI. The same study also failed to show interactions between AGTR2 SNP rs1403543 and VFSD on BMI in Chinese women. Interestingly, this study found that the Malay and Chinese ethnic groups were at a higher risk for elevated lipids compared with the Indian ethnic group [27]. A better understanding of these genes in the context of obesity in different ethnicities is important as the renin-angiotensin system is an important regulator of adipose tissue metabolism, whole-body energy, and glucose homeostasis [47]. Previous studies have shown that overexpression of the adipose renin-angiotensin system could be associated with obesity [48].
The fourth cross-sectional study (n = 179) examined the interaction between VEGFR2 SNP rs1870377 and meat, rice, and noodles diet on BMI in the Chinese population and showed no significant interaction [28]. Previous in vivo studies to understand the role of VEGFR1 and VEGFR2 in angiogenesis in diet-induced obesity have shown that VEGFR2 antiangiogenic blockade may limit adipose tissue expansion in obesity [49]. Studies in larger populations of different ethnicities are needed to better understand this mechanism in the context of ethnic-specific gene–nutrient interaction as this may be a potential target for obesity prevention and treatment strategies.
The final study is an RCT (n = 128) in the Malaysian population that observed the interaction between FTO (rs9930501, rs9930506, rs9932754) and ADRB2 (rs1042713, rs1042714) gene variants and Hipcref (high-protein, calorie-restricted, high-vitamin E, and high-fiber) diet pattern on BMI, body weight, WC, WHR, fat mass, body fat percentage (BFP) and muscle mass in the Chinese, Malay, and Indian ethnicities. However, this study failed to show any significant interaction between these genes and dietary patterns on the abovementioned obesity-related parameters [26]. The FTO and ADRB2 genes are widely studied specifically in relation to obesity [26,50]. An interesting finding from previous literature showed that FTO carriers of heterozygous risk alleles could still have a protective effect against obesity when subjected to increased physical activity and by following an appropriate weight loss regimen. Homozygous carriers of the ADRB2 allele (G > A genotype) have been linked to lower levels of lipid mobilization, which could provide insights into creating dietary plans and obesity prevention strategies for various ethnicities [26]. Further understanding of this concept in larger groups in the SE Asian population may yield promising outcomes in the field of nutrigenetics to target obesity.

3.2.2. Indonesia

Seven studies analyzed gene–diet interactions on obesity-related parameters in the Indonesian population: four cross-sectional [12,21,31,32], two prospective cohort studies [29,33] and one case–control study [30].
A cross-sectional study in 110 Minangkabau women of Indonesia showed significant interaction (Pinteraction = 0.049) between vitamin D GRS (DHCR7, CYP2R1, CYP24A1, GC, CASR) and carbohydrate intake on BFP. The results indicated that participants carrying more than two risk alleles and who consumed high carbohydrate intake had significantly higher BFP than participants with less than two risk alleles. However, there was no significant interaction between metabolic-GRS (FTO, TCF7L2, MC4R, KCNQ1, CDKN2A/B) and carbohydrate or protein intake on obesity-related parameters [12]. Another cross-sectional study in 117 Minangkabau women showed significant interaction (Pinteraction = 0.034) between vitamin D-associated 9-SNP-B12-GRS and protein intake on BFP. The same study also indicated a significant interaction (Pinteraction = 0.032) between vitamin D-associated 9-SNP-metabolic-GRS and protein energy on WC, indicating that women consuming a low fiber diet (4.90 ± 1.00 g/day) and harboring ≥9 risk alleles for vitamin B12 deficiency had notably higher HbA1C levels than the others (Pinteraction = 0.025) [32]. There are many mechanisms proposed to understand the role of Vitamin D levels and obesity including increased fat stores and increased vitamin D storage in adipose tissue. This also considers the lifestyle differences between obese and lean individuals along with combinatorial effects of dietary patterns to have a significant effect on obesity [51]. Further studies are needed to confirm the exact mechanism behind gene–diet interaction on these obesity-related parameters.
One study on 455 Indonesian adults from Yogyakarta examined that coffee consumption and carriers of UCP2 SNP rs659366 AA + GA genotype had a negative correlation with BMI (Pinteraction = 0.01) and body fat (kg) (Pinteraction = 0.021) levels. The same study also showed that carriers of the GG genotype had no correlation with coffee consumption and obesity, indicating that gene variations and coffee intake influences obesity-related parameters [31]. Previous studies have elucidated the potential anti-obesity properties of tea and coffee [52]. Scientific evidence shows possible mechanisms of this activity via cell cycle regulation in adipocytes during adipogenesis, the effect on transcription factors involved in weight loss, and lipogenesis-related proteins [53]. However, further ethnic-specific research is needed to better understand these mechanisms as this proves to be a promising strategy to combat obesity due to the large global consumption of coffee.
Another study in 110 Minangkabau women observed that carriers of more than six risk alleles of a 15-SNP-GRS for cardiometabolic disease and consuming low protein intake had significantly (Pinteraction = 0.002) lower WC compared to carriers of less than six risk alleles. In addition, the study also showed a significant influence of GRS on WC and triglyceride levels through a low-protein diet specifically in Minangkabau women [21]. One prospective cohort study in the Indonesian adult population examined the interaction between two UCP2 gene variations ((rs659366 (−866G/A) AA + GA Genotype) and rs659366 (−866G/A) GG Genotype) and dietary factors on obesity-related outcomes (body weight, BFP, waist-hip ratio (WHR)). There were no significant interactions observed between UCP2 gene variations and any of the dietary factors on the obesity-related parameters; however, significant interaction depicting a positive correlation between UCP2 SNP rs659366 (−866G/A) GG genotype and total energy intake on body weight change (Pinteraction = 0.016) and BFP (Pinteraction = 0.034) was observed. The same study also showed significant interaction (Pinteraction = 0.040) between UCP2 SNP rs659366 (−866G/A) GG genotype and physical activity on WHR indicating that participants with increased physical activity and the UCP2 gene variant had lower WHR [29]. Further studies on larger populations are required to validate these results and elucidate the mechanisms.
Another study showed a significant interaction (Pinteraction = 0.032) between 2-SNP-GRS and carbohydrate intake on infant birth length. Pregnant women with >2 risk alleles of VDR-GRS and low vitamin D status and who consumed a high carbohydrate diet (405.88 ± 57.16 g/day) during the third trimester gave birth to babies with a lower birth length. This could suggest the benefits of low carbohydrate intake in Indonesian women with >2 risk alleles of VDR-GRS and low vitamin D status, but would need validation from further studies [33].
A case–control study of 261 Indonesian adolescents showed significant interaction (Pinteraction = 0.006) between fat intake and the UCP2 SNP rs659366 on obesity risk. This study also indicated that carriers of UCP2 SNP rs659366 who consumed a high-fat diet had a lower chance of becoming obese compared to non-carriers with normal fat intake [30]. UCP2 gene variants are very commonly studied in association with obesity. The best--understood mechanisms of UCP2-mediated regulation of obesity include: (a) direct activation of melanocortin-4 receptor that increases energy expenditure and decreases food intake and (b) negative regulation of glucose-dependent insulin secretion in the beta cells of the pancreas and positive regulation of glucagon from the alpha cells [54]. It is also understood that UCP2 expression has a positive correlation with weight loss [55].

3.2.3. Singapore

Four Singaporean studies examined gene–diet interactions on obesity-related outcomes [34,35,36,37]. A study on 7817 Singaporeans examining the interaction between CCDC SNP rs4740619 variant and cholesterol intake on BMI in the Chinese ethnicity showed a statistically significant interaction (Pinteraction = 0.043) between SNP rs4740619 and cholesterol intake on change in BMI. This study also indicated that this new locus identified does not commonly interact with dietary factors but proves an association in the SE Asian population [34]. An initially proposed mechanism according to the HaploReg analysis (tool to investigate the non-coding genome annotations from published GWAS (genome-wide association study) or novel variants) describes a possible alteration in the binding affinity of peroxisome proliferator-activated receptors regulating multiple metabolic pathways in obesity, but further studies are required to precisely determine the actual mechanism of CCDC SNP rs4740619 variant in obesity [56].
A 10-year prospective cohort study on 5264 individuals of Chinese ethnicity examined the interactions between FADS SNP rs174570 and total fish, food-sourced eicosapentaenoic acid (EPA) + docosahexaenoic acid (DHA) on BMI. The study showed significant interaction (Pinteraction = 0.035) and a long-term increase in BMI in individuals carrying the signature ‘T’ allele with high fish/n-3 polyunsaturated fatty acids (PUFA) intake [35]. It is also well understood that FADS1 and FADS2 are involved in the rate-limiting steps of the fatty acid metabolic pathway and are consistently associated with plasma and tissue levels of arachidonic acid and EPA [57].
APOA2 is associated with high-density lipoproteins, reverse cholesterol transport impairment, antioxidant properties, and fat distribution phenotypes that are associated with metabolic disease progression [58]. Here, a multi-ethnic cross-sectional study on 3605 Singaporeans of the Chinese, Malay, and Indian ethnicities examining saturated fatty acid (SFA) intake and APOA2 SNP rs5082 on BMI showed no significant interaction [36]. A similar study in 4038 individuals also showed no significant interaction between PUFA/saturated fatty acids (SFA) and PPAR-γ SNPs rs1801282 and rs3856806 on BMI [37]. Further analysis of different APOA2 gene variants may provide insights into gene–diet interactions specific to the SE Asian population.

3.3. Gene–Diet Interactions on Diabetes-Related Outcomes in the Southeast Asian Population

Gene–diet interactions on diabetes-related traits were observed in six Malaysian, three Indonesian, and four Singaporean studies (Figure 3, Table 2).

3.3.1. Malaysia

The gene–diet interactions on diabetes-related outcomes in the Malaysian population were investigated by six studies: one RCT [26] and five cross-sectional studies [24,27,28,38,39].
One RCT in 128 Malaysian participants examined the interaction between FTO (rs9930501, rs9930506, rs9932754) and ADRB2 (rs1042713, rs1042714) gene variants and Hipcref diet on diabetes-related outcomes in the Malay, Chinese, and Indian ethnic groups. This study showed a significant interaction (Pinteraction = 0.048) indicating that participants had a reduction in hs-CRP level in the Hipcref-PRS interventional diet compared to normal diets [26]. This is a notable association because the FTO gene variants are not only linked with obesity but also have a strong association with diabetes [59]. When the FTO gene is overexpressed in INS-1 pancreatic beta cells, it upregulates transcription factor 7-like 2 (TCF7L2) which is a key determinant of diabetes [60]. ADRB2 is also another gene understood to play a pivotal role in glucose homeostasis. In vivo studies have shown that pancreas-specific deletion of the ADRB2 gene in the pancreas impacts not only glucose secretion and tolerance, but also increases VEGF-A production. This has a direct effect on impaired insulin production, exocytosis, and accelerates the development of diabetes-related complications like retinopathy and macular edema [61].
A cross-sectional study of 507 participants showed no significant interaction between AGTR 1 SNP rs5186, AGTR2 SNP rs1403543, and VFSD in Malay, REFD in Chinese, and VFSD in Chinese females on HbA1c levels [27]. A previous study reported several AGTR1 gene variants expressed in several tissues such as blood vessels, kidneys, and lungs and once expressed, lead to water–sodium retention, elevated blood pressure, and microvascular disorders in diabetes [62]. Another study (n = 179) in the Chinese ethnic group examined VEGFR2 SNP rs1870377 and meat, rice, and noodles diet on blood glucose and HbA1c also showed no significant interaction [28]. A better understanding of this relationship in the context of gene–diet interaction is important because inhibition/downregulation of the VEGFR2 signaling axis is associated with endothelial dysfunction in diabetes [63].
One study conducted on 200 participants of the Chinese and Indian ethnic groups to understand the interaction of FADS1 SNP rs174547 and LA, ALA intake on fasting blood glucose levels showed no statistically significant interactions [24]. A cross-sectional study (n = 211) performed on the Chinese ethnic group to understand the interaction of IGF1 rs35767, IGF1 rs7136446, IL6 rs1800796, and DAL intake (using PRAL levels) on fasting blood glucose also showed no significant interaction [38]. IGF1, with structural homology to insulin, is responsible for increased peripheral glucose intake and reduction in hepatic glucose production for better insulin sensitivity. When IGF1 levels are lower, it is often associated with higher anthropometric variables correlating with insulin resistance [64]. IL6 is a pro-inflammatory cytokine with a known mechanism to develop insulin resistance and is involved in the pathogenesis of diabetes. This is often the result of its irregular expression (usually genetic) and long-term exposure leading to inflammation that induces insulin resistance and increases the overall risk of diabetes [65].
The fifth cross-sectional study (n = 126) on Malaysian, Chinese, and Indian ethnic groups to understand the interaction between ADRB2 SNP rs1042713 and saturated fat, PUFA intake on diabetes-related outcomes showed significant gene–diet interactions on fasting blood glucose (Pinteraction = 0.011), HOMA-IR (Pinteraction = 0.026) and fasting insulin (Pinteraction = 0.036). This study also showed that G allele carriers of ADRB2 SNP rs1042713 were associated with increased odds of developing insulin resistance [39]. Understanding this gene–diet interaction in diabetes is important because ADRB2 has shown close associations with diabetes by directly influencing anthropometric measures, fasting insulin level, and insulin resistance [61].

3.3.2. Indonesia

Three cross-sectional studies were performed on Minangkabau women of Indonesia to understand the significance of gene–diet interaction in diabetes-related outcomes.
One cross-sectional study (n = 117) showed significant interaction (Pinteraction = 0.042) between vitamin B12 GRS and fiber intake on HbA1C levels. Interestingly, the study also showed that individuals with ≥9 risk alleles who consumed a low-fiber diet had higher HbA1c levels indicating a significant interaction between B12 GRS and dietary factor [32]. Vitamin B12 deficiency in diabetic patients with metformin is quite common compared to the relationship between vitamin B12 deficiency in individuals who are not administered metformin medication. It was interesting to note that a previous study in the Chinese population (n = 16,699) demonstrated that individuals who did not take metformin as a part of their treatment regime had significantly higher B12 deficiency [66]. This poses a need for further studies on larger groups of SE Asians to understand the interaction between B12 GRS and dietary factors on diabetes-related outcomes.
The second study (n = 110) showed no significant interaction between Metabolic GRS [FTO, TCF7L2, MC4R, KCNQ1, CDKN2A/B] and dietary factors on diabetes-related outcomes (glucose, HbA1C, fasting insulin) [12]. The third cross-sectional study (n = 110) on Minangkabau women who were carriers of more than six risk alleles of a 15-SNP-cardiometabolic disease GRS also showed no significant interaction with protein intake on glucose levels, HbA1c levels, and fasting insulin [21]. These studies in the Indonesian population show the importance of understanding gene–diet interaction on diabetes-related outcomes, but further analysis on larger populations is required to validate these results.

3.3.3. Singapore

A total of four studies were identified: three cross-sectional studies [36,37,41], and one prospective cohort study [40]. A total of fifteen gene–diet interactions on diabetes- related traits have been identified in these studies, mostly by Corella et. al [41]. This extensive cross-sectional study on 4017 participants of the Chinese, Malay, and Indian ethnic groups showed several significant interactions between gene variants (PLIN rs894160, rs1052700) and dietary factors (total fat, carbohydrates, SFA) [41].
Another study (n = 3605) identified a significant interaction (Pinteraction = 0.026) between apolipoprotein A2 (APOA2) SNP rs5082 and high SFA intake on homeostasis model assessment-estimated insulin resistance (HOMA-IR) in individuals who are carriers of the CC genotype of the variant in the Chinese, Asian, and Indian ethnicities [36]. These results are in line with another French–Caucasian case–control cohort (n = 12,387) study where the authors found an association between APOA2 and diabetes, specifically the SNP rs5082 variant [67]. In vivo studies have also understood the mechanism of APOA2 in diabetes where overexpression of the APOA2 gene significantly resulted in elevated fasting blood glucose and a two-fold increase in plasma insulin levels that are key features of insulin resistance [68].
Peroxisome proliferator-activated receptor gamma (PPAR-γ) has been a prime subject of diabetes research because its ligands have been shown to be potential insulin sensitizers for the treatment of diabetes [69]. Contrastingly, Tai et. al (n = 4038), revealed that there were no interactions between the PUFA/SFA intake ratio and the PPAR-γ SNPs rs1801282 and rs3856806 on fasting insulin [37]. In addition, a prospective cohort study (n = 38,434) with a mean follow-up of 10.72 years examined DM-37-SNP GRS and dietary patterns (alcohol, vegetable-fruit-soy pattern, meat dim-sum pattern) on diabetes and found no significant interactions [40].
The above studies provide a complete picture of the nutrigenetic status of obesity and diabetes in the SE Asian population. Although the studies are in their infancy and are required to be understood by larger populations and all countries of the ASEAN, this research provides comparable results with similar gene–diet interactions with other parts of the world. A meta-analysis in the French population (n = 3069) confirmed an interaction (Pinteraction = 0.0005) between low LA intake and FADS1 rs174547 on low WC and BMI. The same study also indicated that minor allele carriers of FADS1 SNP rs174547 benefitted from a lower dietary intake of LA [70]. A previous systematic analysis of a GLACIER study in the Swedish population (n = 5160) indicated that high PUFA intake modified the association between FADS1,2,3 gene cluster variants (rs74771917, rs3168072, rs12577276, rs7115739, rs174602, and rs174570) and triglycerides [71]. Though not all PLIN variants have been associated with diabetes, some studies in American (n = 431) [72] and Chinese (n = 993) [73] women have shown a significant association between certain PLIN variants and the risk of diabetes. This emphasizes the need to validate the results of the above-mentioned gene–diet interaction on larger groups of the SE Asian population.

4. Precision Nutrition Approach for the Southeast Asian Population

The understanding of genetic diversity between individuals and among different ethnic groups should be established before designing dietary and nutritional requirements because different individuals respond differently to lifestyle interventions. Human genome sequencing plays a pivotal role in understanding genetic variations among different ethnic groups and has paved the way for the concept of personalized nutrition to frame effective lifestyle intervention strategies [74]. Developments in omics technology provide a better understanding of the whole genome of individuals as well as different ethnic groups along with the transcriptome, proteome, metabolome, and metagenome [75]. Integration of Artificial Intelligence along with gene nutrient analysis, especially in populations such as SE Asia will be useful to develop public health strategies and personalized nutrition plans for cardiometabolic diseases such as obesity and diabetes.
A high-throughput genetic screening has been developed to understand the role of SNPs in cardiometabolic diseases. However, molecular and pathophysiological mechanisms to understand gene–nutrient interactions and its influence on cardiometabolic diseases remain unexplored. In LMIC such as in SE Asia, nutrigenetics is still in its infancy and requires an evidence-based approach before framing precision nutrition strategies for the population. Further, such studies on larger populations and ethnic groups as well as on different levels of nutrition transition, are crucial for the development of accurate and population-specific precision nutrition strategies effective to combat chronic, yet preventable diseases such as obesity and diabetes [2]. While the Western countries have shifted their approach towards nutrigenetics, developing countries like SE Asia still favor traditional methods for evaluating, categorizing, and managing obesity and diabetes. Costly gene testing, lack of knowledge, and experts in this field are the primary impediments of nutrigenetics implementation, particularly in LMIC. Even though this field is expanding globally, there are not many researchers in this discipline in SE Asia. Moving forward, the nutrigenetics approach should be considered for government health programs, particularly those aimed at noncommunicable diseases (NCDs). Currently, lifestyle diseases are a major burden to all countries, and long-term investments in accelerating nutrigenetics research and generating scientific evidence may provide a solution to obesity and its comorbidities through precision nutrition.

5. Limitations

Our study sought to analyze the gene–diet interactions on metabolic disease-related parameters in the SE Asian population. This review included twenty studies conducted in Malaysia, Indonesia, and Singapore (Figure 4) with four Indonesian studies focusing on Minangkabau women—a minority ethnic group. To the best of our knowledge, there are no articles examining gene–diet interactions on metabolic-disease-related outcomes in eight out of 11 ASEAN countries. Hence, the results of this review cannot be applied to the entire SE Asian population due to a lack of consistency and replication in dietary exposures and individual SNPs. Given these limitations, there was no possibility of a meta-analysis. Most studies performed had a cross-sectional study design and the sample size was insufficient to apply the results to the entirety of the SE Asian population. Some studies explored the relationship between SNPs and dietary factors, but there could have been an influence of other SNPs on the same outcome that remains unexplored. On performing ROBINS-1 risk assessment, one prospective cohort study was found to be at a higher risk of bias where participants were not screened for gestational diabetes which could have been a confounder in the study [33]. Future research needs to consider the general limitations highlighted in the present study and emphasize ethnic differences when looking at multi-ethnic populations.

6. Conclusions

This is the first systematic analysis of the effects of gene–diet interactions on obesity and diabetes in the Southeast Asian population. This review highlights several population-, sex-, and ethnicity-specific gene–diet interactions that are significant in Malaysian, Indonesian, and Singaporean populations and provide a complete picture of nutrigenetic research conducted in SE Asia. The commonly reported interactions were between macronutrients and GRS such as B12-GRS, vitamin D GRS, and a metabolic-GRS, and there were multiple interactions between UCP2 SNP rs659366 and dietary factors on obesity traits in the Indonesian population, making the UCP2 gene a candidate for further studies to understand the mechanisms of interaction. A deeper understanding of the UCP2 gene–diet interaction and studies on larger groups of the SE Asian population may provide insights into personalized nutrition strategy development. Additionally, some Malaysian studies examined gene–diet interactions with specific dietary patterns in population subgroups including FTO, ADRB2, and Hipcref diet, AGTR1, AGTR2 genes, and VFSD, REFD diets, and VEGFR2 with a meat, rice, noodles diet to better understand its influence on obesity and diabetes [26,27,28]. Similar such studies are crucial in larger populations and ethnic groups for the development of accurate, population-specific precision nutrition strategies to effectively combat chronic, yet preventable diseases such as obesity and diabetes.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/nu15132948/s1, Table S1. Number of Hits and Search Strings per Database. Table S2. Summary Outcome of Assessment with the Appraisal Tool for Cross-Sectional Studies (AXIS). Table S3. Assessment with the Comments Appraisal Tool for Cross-Sectional Studies. Table S4. Assessment using the Risk of Bias in Non-Randomized Studies—of Interventions (ROBINS-I) [29,33,34,35,40]. Table S5. Assessment using RoB 2: A revised Cochrane risk-of-bias tool for randomized trials. Section S1—Risk of bias assessment.

Author Contributions

Conceptualization, K.S.V.; methodology, P.S., E.F.V., A.C.T.A.D. and E.S.G.C.; validation, K.S.V., E.F.V., A.L. and P.S.; writing—original draft preparation, P.S., E.F.V. and K.S.V.; writing—review and editing, P.S., E.F.V., K.S.V., J.A.L., A.C.T.A.D., E.S.G.C., A.L., P.L.Q., M.A., N.A.T., H.H., M.F.M.N. and I.G.; visualization, P.S., E.F.V. and K.S.V.; supervision, K.S.V.; project administration, K.S.V.; funding acquisition, K.S.V. and A.C.T.A.D. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the British Council-Malaysian Industry Government Group for High Technology (MIGHT) BC-REL Going Global Partnership Grant (Grant ID: 871106314).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The original contributions presented in this study are included in the Supplementary material. Further inquiries can be directed to the corresponding author.

Acknowledgments

We thank the funding body for their consistent support for the provisions to carry on with this review article.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. Di Cesare, M.; Sorić, M.; Bovet, P.; Miranda, J.J.; Bhutta, Z.; Stevens, G.A.; Laxmaiah, A.; Kengne, A.P.; Bentham, J. The epidemiological burden of obesity in childhood: A worldwide epidemic requiring urgent action. BMC Med. 2019, 17, 212. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Vimaleswaran, K.S. GeNuIne (gene-nutrient interactions) Collaboration: Towards implementing multi-ethnic population-based nutrigenetic studies of vitamin B(12) and D deficiencies and metabolic diseases. Proc. Nutr. Soc. 2021, 80, 1–11. [Google Scholar] [CrossRef] [PubMed]
  3. World Health Organisation. Obesity. Available online: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight (accessed on 3 November 2022).
  4. World Health Organisation. Diabetes. Available online: https://www.who.int/news-room/fact-sheets/detail/diabetes (accessed on 3 November 2022).
  5. World Health Organisation. Obesity and Overweight in South East Asia. Available online: https://www.who.int/southeastasia/health-topics/obesity (accessed on 3 November 2022).
  6. Biswas, T.; Townsend, N.; Magalhaes, R.J.S.; Islam, M.S.; Hasan, M.M.; Mamun, A. Current Progress and Future Directions in the Double Burden of Malnutrition among Women in South and Southeast Asian Countries. Curr. Dev. Nutr. 2019, 3, nzz026. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Association of Southeast Asian Nations: ASEAN Food and Nutrition Security Report 2021, Volume 1. Available online: https://asean.org/book/asean-food-and-nutrition-security-report-2021-volume-1-the-asean-secretariat-jakarta/ (accessed on 4 November 2022).
  8. ASEAN Food and Nutrition Security Report 2021 Volume 2—Food and Nutrition Security Country Profiles. Available online: https://asean.org/book/asean-food-and-nutrition-security-report-2021-volume-2-food-and-nutrition-security-country-profiles/ (accessed on 8 November 2022).
  9. Phillips, C.M. Nutrigenetics and metabolic disease: Current status and implications for personalised nutrition. Nutrients 2013, 5, 32–57. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  10. Vimaleswaran, K.S.; Franks, P.W.; Barroso, I.; Brage, S.; Ekelund, U.; Wareham, N.J.; Loos, R.J. Habitual energy expenditure modifies the association between NOS3 gene polymorphisms and blood pressure. Am. J. Hypertens. 2008, 21, 297–302. [Google Scholar] [CrossRef] [Green Version]
  11. Vimaleswaran, K.S.; Li, S.; Zhao, J.H.; Luan, J.; Bingham, S.A.; Khaw, K.T.; Ekelund, U.; Wareham, N.J.; Loos, R.J. Physical activity attenuates the body mass index-increasing influence of genetic variation in the FTO gene. Am. J. Clin. Nutr. 2009, 90, 425–428. [Google Scholar] [CrossRef] [Green Version]
  12. Alathari, B.E.; Aji, A.S.; Ariyasra, U.; Sari, S.R.; Tasrif, N.; Yani, F.F.; Sudji, I.R.; Lovegrove, J.A.; Lipoeto, N.I.; Vimaleswaran, K.S. Interaction between Vitamin D-Related Genetic Risk Score and Carbohydrate Intake on Body Fat Composition: A Study in Southeast Asian Minangkabau Women. Nutrients 2021, 13, 326. [Google Scholar] [CrossRef]
  13. Bodhini, D.; Gaal, S.; Shatwan, I.; Ramya, K.; Ellahi, B.; Surendran, S.; Sudha, V.; Anjana, M.R.; Mohan, V.; Lovegrove, J.A.; et al. Interaction between TCF7L2 polymorphism and dietary fat intake on high density lipoprotein cholesterol. PLoS ONE 2017, 12, e0188382. [Google Scholar] [CrossRef] [Green Version]
  14. Vimaleswaran, K.S.; Bodhini, D.; Lakshmipriya, N.; Ramya, K.; Anjana, R.M.; Sudha, V.; Lovegrove, J.A.; Kinra, S.; Mohan, V.; Radha, V. Interaction between FTO gene variants and lifestyle factors on metabolic traits in an Asian Indian population. Nutr. Metab. 2016, 13, 39. [Google Scholar] [CrossRef] [Green Version]
  15. Vimaleswaran, K.S.; Cavadino, A.; Hyppönen, E. APOA5 genotype influences the association between 25-hydroxyvitamin D and high density lipoprotein cholesterol. Atherosclerosis 2013, 228, 188–192. [Google Scholar] [CrossRef] [Green Version]
  16. Bishwajit, G. Nutrition transition in South Asia: The emergence of non-communicable chronic diseases. F1000Res 2015, 4, 8. [Google Scholar] [CrossRef] [PubMed]
  17. Williams, R.; Periasamy, M. Genetic and Environmental Factors Contributing to Visceral Adiposity in Asian Populations. Endocrinol Metab 2020, 35, 681–695. [Google Scholar] [CrossRef] [PubMed]
  18. Wuni, R.; Adela Nathania, E.; Ayyappa, A.K.; Lakshmipriya, N.; Ramya, K.; Gayathri, R.; Geetha, G.; Anjana, R.M.; Kuhnle, G.G.C.; Radha, V.; et al. Impact of Lipid Genetic Risk Score and Saturated Fatty Acid Intake on Central Obesity in an Asian Indian Population. Nutrients 2022, 14, 2713. [Google Scholar] [CrossRef] [PubMed]
  19. Wuni, R.; Kuhnle, G.G.C.; Wynn-Jones, A.A.; Vimaleswaran, K.S. A Nutrigenetic Update on CETP Gene-Diet Interactions on Lipid-Related Outcomes. Curr. Atheroscler. Rep. 2022, 24, 119–132. [Google Scholar] [CrossRef] [PubMed]
  20. Vimaleswaran, K.S. A nutrigenetics approach to study the impact of genetic and lifestyle factors on cardiometabolic traits in various ethnic groups: Findings from the GeNuIne Collaboration. Proc. Nutr. Soc. 2020, 79, 194–204. [Google Scholar] [CrossRef]
  21. Alsulami, S.; Aji, A.S.; Ariyasra, U.; Sari, S.R.; Tasrif, N.; Yani, F.F.; Lovegrove, J.A.; Sudji, I.R.; Lipoeto, N.I.; Vimaleswaran, K.S. Interaction between the genetic risk score and dietary protein intake on cardiometabolic traits in Southeast Asian. Genes Nutr. 2020, 15, 19. [Google Scholar] [CrossRef]
  22. Dhanapal, A.; Wuni, R.; Ventura, E.F.; Chiet, T.K.; Cheah, E.S.G.; Loganathan, A.; Quen, P.L.; Appukutty, M.; Noh, M.F.M.; Givens, I.; et al. Implementation of Nutrigenetics and Nutrigenomics Research and Training Activities for Developing Precision Nutrition Strategies in Malaysia. Nutrients 2022, 14, 5108. [Google Scholar] [CrossRef]
  23. Thiruvenkataswamy, C.S.; Appukutty, M.; Vimaleswaran, K.S. Role of precision nutrition in improving military performance. Pers. Med. 2022, 19, 167–170. [Google Scholar] [CrossRef]
  24. Ching, Y.K.; Chin, Y.S.; Appukutty, M.; Ramanchadran, V.; Yu, C.Y.; Ang, G.Y.; Gan, W.Y.; Chan, Y.M.; Teh, L.K.; Salleh, M.Z. Interaction of Dietary Linoleic Acid and α-Linolenic Acids with rs174547 in FADS1 Gene on Metabolic Syndrome Components among Vegetarians. Nutrients 2019, 11, 1686. [Google Scholar] [CrossRef] [Green Version]
  25. Lee, S.S.; Ling, K.H.; Tusimin, M.; Subramaniam, R.; Rahim, K.F.; Loh, S.P. Interplay between Maternal and Neonatal Vitamin D Deficiency and Vitamin-D-Related Gene Polymorphism with Neonatal Birth Anthropometry. Nutrients 2022, 14, 564. [Google Scholar] [CrossRef]
  26. Tan, P.Y.; Mitra, S.R. The Combined Effect of Polygenic Risk from FTO and ADRB2 Gene Variants, Odds of Obesity, and Post-Hipcref Diet Differences. Lifestyle Genom. 2020, 13, 84–98. [Google Scholar] [CrossRef] [PubMed]
  27. Yap, R.W.K.; Shidoji, Y.; Yap, W.S.; Masaki, M. Association and Interaction Effect of AGTR1 and AGTR2 Gene Polymorphisms with Dietary Pattern on Metabolic Risk Factors of Cardiovascular Disease in Malaysian Adults. Nutrients 2017, 9, 853. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Yap, R.W.; Shidoji, Y.; Hon, W.M.; Masaki, M. Interaction between VEGF receptor-2 gene polymorphisms and dietary patterns on blood glucose and lipid levels in Chinese Malaysian adults. J. Nutr. Nutr. 2011, 4, 309–321. [Google Scholar] [CrossRef]
  29. Muhammad, H.F.L.; Sulistyoningrum, D.C.; Huriyati, E.; Lee, Y.Y.; Muda, W. The interaction between energy intake, physical activity and UCP2 -866G/A gene variation on weight gain and changes in adiposity: An Indonesian Nutrigenetic Cohort (INDOGENIC). Br. J. Nutr. 2021, 125, 611–617. [Google Scholar] [CrossRef] [PubMed]
  30. Huriyati, E.; Luglio, H.F.; Ratrikaningtyas, P.D.; Tsani, A.F.; Sadewa, A.H.; Juffrie, M. Dyslipidemia, insulin resistance and dietary fat intake in obese and normal weight adolescents: The role of uncoupling protein 2 -866G/A gene polymorphism. TInt. J. Mol. Epidemiol. Genet. 2016, 7, 67–73. [Google Scholar]
  31. Muhammad, H.F.L.; Sulistyoningrum, D.C.; Huriyati, E.; Lee, Y.Y.; Manan Wan Muda, W.A. The Interaction between Coffee: Caffeine Consumption, UCP2 Gene Variation, and Adiposity in Adults-A Cross-Sectional Study. J. Nutr. Metab. 2019, 2019, 9606054. [Google Scholar] [CrossRef]
  32. Surendran, S.; Aji, A.S.; Ariyasra, U.; Sari, S.R.; Malik, S.G.; Tasrif, N.; Yani, F.F.; Lovegrove, J.A.; Sudji, I.R.; Lipoeto, N.I.; et al. A nutrigenetic approach for investigating the relationship between vitamin B12 status and metabolic traits in Indonesian women. J. Diabetes Metab. Disord. 2019, 18, 389–399. [Google Scholar] [CrossRef] [Green Version]
  33. Aji, A.S.; Lipoeto, N.I.; Yusrawati, Y.; Malik, S.G.; Kusmayanti, N.A.; Susanto, I.; Nurunniyah, S.; Alfiana, R.D.; Wahyuningsih, W.; Majidah, N.M.; et al. Impact of maternal dietary carbohydrate intake and vitamin D-related genetic risk score on birth length: The Vitamin D Pregnant Mother (VDPM) cohort study. BMC Pregnancy Childbirth 2022, 22, 690. [Google Scholar] [CrossRef]
  34. Chang, X.; Dorajoo, R.; Sun, Y.; Han, Y.; Wang, L.; Khor, C.C.; Sim, X.; Tai, E.S.; Liu, J.; Yuan, J.M.; et al. Gene-diet interaction effects on BMI levels in the Singapore Chinese population. Nutr. J. 2018, 17, 31. [Google Scholar] [CrossRef]
  35. Huang, T.; Wang, T.; Heianza, Y.; Wiggs, J.; Sun, D.; Choi, H.K.; Chai, J.F.; Sim, X.; Khor, C.C.; Friedlander, Y.; et al. Fish and marine fatty acids intakes, the FADS genotypes and long-term weight gain: A prospective cohort study. BMJ Open 2019, 9, e022877. [Google Scholar] [CrossRef] [Green Version]
  36. Corella, D.; Tai, E.S.; Sorlí, J.V.; Chew, S.K.; Coltell, O.; Sotos-Prieto, M.; García-Rios, A.; Estruch, R.; Ordovas, J.M. Association between the APOA2 promoter polymorphism and body weight in Mediterranean and Asian populations: Replication of a gene-saturated fat interaction. Int. J. Obes. 2011, 35, 666–675. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Tai, E.S.; Corella, D.; Deurenberg-Yap, M.; Adiconis, X.; Chew, S.K.; Tan, C.E.; Ordovas, J.M. Differential effects of the C1431T and Pro12Ala PPARgamma gene variants on plasma lipids and diabetes risk in an Asian population. J. Lipid Res. 2004, 45, 674–685. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Lim, S.Y.; Chan, Y.M.; Ramachandran, V.; Shariff, Z.M.; Chin, Y.S.; Arumugam, M. Dietary Acid Load and Its Interaction with IGF1 (rs35767 and rs7136446) and IL6 (rs1800796) Polymorphisms on Metabolic Traits among Postmenopausal Women. Nutrients 2021, 13, 2161. [Google Scholar] [CrossRef] [PubMed]
  39. Mitra, S.R.; Tan, P.Y.; Amini, F. Association of ADRB2 rs1042713 with Obesity and Obesity-Related Phenotypes and Its Interaction with Dietary Fat in Modulating Glycaemic Indices in Malaysian Adults. J. Nutr. Metab. 2019, 2019, 8718795. [Google Scholar] [PubMed] [Green Version]
  40. Li, H.; Khor, C.C.; Fan, J.; Lv, J.; Yu, C.; Guo, Y.; Bian, Z.; Yang, L.; Millwood, I.Y.; Walters, R.G.; et al. Genetic risk, adherence to a healthy lifestyle, and type 2 diabetes risk among 550,000 Chinese adults: Results from 2 independent Asian cohorts. Am. J. Clin. Nutr. 2020, 111, 698–707. [Google Scholar] [PubMed] [Green Version]
  41. Corella, D.; Qi, L.; Tai, E.S.; Deurenberg-Yap, M.; Tan, C.E.; Chew, S.K.; Ordovas, J.M. Perilipin gene variation determines higher susceptibility to insulin resistance in Asian women when consuming a high-saturated fat, low-carbohydrate diet. Diabetes Care 2006, 29, 1313–1319. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Downes, M.J.; Brennan, M.L.; Williams, H.C.; Dean, R.S. Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS). BMJ Open 2016, 6, e011458. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Sterne, J.A.; Hernán, M.A.; Reeves, B.C.; Savović, J.; Berkman, N.D.; Viswanathan, M.; Henry, D.; Altman, D.G.; Ansari, M.T.; Boutron, I.; et al. ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016, 355, i4919. [Google Scholar] [CrossRef] [Green Version]
  44. RoB 2: A Revised Cochrane Risk-Of-Bias Tool for Randomized Trials|Cochrane Bias. Available online: https://methods.cochrane.org/bias/resources/rob-2-revised-cochrane-risk-bias-tool-randomized-trials (accessed on 24 October 2022).
  45. Liu, S.J.; Zhi, H.; Chen, P.Z.; Chen, W.; Lu, F.; Ma, G.S.; Dai, J.C.; Shen, C.; Liu, N.F.; Hu, Z.B.; et al. Fatty acid desaturase 1 polymorphisms are associated with coronary heart disease in a Chinese population. Chin. Med. J. 2012, 125, 801–806. [Google Scholar]
  46. Agarwal, S.; Kovilam, O.; Agrawal, D.K. Vitamin D and its impact on maternal-fetal outcomes in pregnancy: A critical review. Crit. Rev. Food Sci. Nutr. 2018, 58, 755–769. [Google Scholar] [CrossRef]
  47. Cohen, J.B.; Stephens-Shields, A.J.; Denburg, M.R.; Anderson, A.H.; Townsend, R.R.; Reese, P.P. Obesity, Renin-Angiotensin System Blockade and Risk of Adverse Renal Outcomes: A Population-Based Cohort Study. Am. J. Nephrol. 2016, 43, 431–440. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  48. Pahlavani, M.; Kalupahana, N.S.; Ramalingam, L.; Moustaid-Moussa, N. Regulation and Functions of the Renin-Angiotensin System in White and Brown Adipose Tissue. Compr. Physiol. 2017, 7, 1137–1150. [Google Scholar] [PubMed]
  49. Tam, J.; Duda, D.G.; Perentes, J.Y.; Quadri, R.S.; Fukumura, D.; Jain, R.K. Blockade of VEGFR2 and not VEGFR1 can limit diet-induced fat tissue expansion: Role of local versus bone marrow-derived endothelial cells. PLoS ONE 2009, 4, e4974. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  50. Fawcett, K.A.; Barroso, I. The genetics of obesity: FTO leads the way. Trend Genet. 2010, 26, 266–274. [Google Scholar] [CrossRef] [Green Version]
  51. Abbas, M.A. Physiological functions of Vitamin D in adipose tissue. J. Steroid Biochem. Mol. Biol. 2017, 165, 369–381. [Google Scholar] [CrossRef]
  52. Sirotkin, A.V.; Kolesárová, A. The anti-obesity and health-promoting effects of tea and coffee. Physiol. Res. 2021, 70, 161–168. [Google Scholar] [CrossRef]
  53. Pan, M.H.; Tung, Y.C.; Yang, G.; Li, S.; Ho, C.T. Molecular mechanisms of the anti-obesity effect of bioactive compounds in tea and coffee. Food Funct. 2016, 7, 4481–4491. [Google Scholar]
  54. Li, J.; Jiang, R.; Cong, X.; Zhao, Y. UCP2 gene polymorphisms in obesity and diabetes, and the role of UCP2 in cancer. FEBS Lett. 2019, 593, 2525–2534. [Google Scholar] [CrossRef] [Green Version]
  55. Allister, E.M.; Robson-Doucette, C.A.; Prentice, K.J.; Hardy, A.B.; Sultan, S.; Gaisano, H.Y.; Kong, D.; Gilon, P.; Herrera, P.L.; Lowell, B.B.; et al. UCP2 regulates the glucagon response to fasting and starvation. Diabetes 2013, 62, 1623–1633. [Google Scholar] [CrossRef] [Green Version]
  56. Evans, R.M.; Barish, G.D.; Wang, Y.X. PPARs and the complex journey to obesity. Nat. Med. 2004, 10, 355–361. [Google Scholar] [CrossRef]
  57. Murff, H.J.; Edwards, T.L. Endogenous Production of Long-Chain Polyunsaturated Fatty Acids and Metabolic Disease Risk. Curr. Cardiovasc. Risk Rep. 2014, 8, 1–9. [Google Scholar] [CrossRef] [Green Version]
  58. Zaki, M.E.; Amr, K.S.; Abdel-Hamid, M. APOA2 Polymorphism in Relation to Obesity and Lipid Metabolism. Cholesterol 2013, 2013, 289481. [Google Scholar] [CrossRef] [Green Version]
  59. Wang, Q.; Wang, J.; Lin, H.; Huo, X.; Zhu, Q.; Zhang, M. Relationship between fat mass and obesity-associated gene expression and type 2 diabetes mellitus severity. Exp. Ther. Med. 2018, 15, 2917–2921. [Google Scholar] [CrossRef] [Green Version]
  60. Grant, S.F.; Thorleifsson, G.; Reynisdottir, I.; Benediktsson, R.; Manolescu, A.; Sainz, J.; Helgason, A.; Stefansson, H.; Emilsson, V.; Helgadottir, A.; et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat. Genet. 2006, 38, 320–323. [Google Scholar] [CrossRef] [PubMed]
  61. Ceasrine, A.M.; Lin, E.E.; Lumelsky, D.N.; Iyer, R.; Kuruvilla, R. Adrb2 controls glucose homeostasis by developmental regulation of pancreatic islet vasculature. Elife 2018, 7, e39689. [Google Scholar] [CrossRef] [PubMed]
  62. Zhuang, Y.; Niu, F.; Liu, D.; Sun, J.; Zhang, X.; Zhang, J.; Guo, S. Association between AGTR1 A1166C polymorphism and the susceptibility to diabetic nephropathy: Evidence from a meta-analysis. Medicine 2018, 97, e07689. [Google Scholar] [CrossRef]
  63. Chou, E.; Suzuma, I.; Way, K.J.; Opland, D.; Clermont, A.C.; Naruse, K.; Suzuma, K.; Bowling, N.L.; Vlahos, C.J.; Aiello, L.P.; et al. Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic States: A possible explanation for impaired collateral formation in cardiac tissue. Circulation 2002, 105, 373–379. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Møller, N.; Jørgensen, J.O. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev 2009, 30, 152–177. [Google Scholar] [CrossRef] [Green Version]
  65. Rehman, K.; Akash, M.S.H.; Liaqat, A.; Kamal, S.; Qadir, M.I.; Rasul, A. Role of Interleukin-6 in Development of Insulin Resistance and Type 2 Diabetes Mellitus. Crit. Rev. Eukaryot. Gene Expr. 2017, 27, 229–236. [Google Scholar] [CrossRef]
  66. Liu, L.; Huang, X.; Wang, B.; Song, Y.; Lin, T.; Zhou, Z.; Wang, Z.; Wei, Y.; Guo, H.; Chen, P.; et al. Vitamin B(12) and risk of diabetes: New insight from cross-sectional and longitudinal analyses of the China Stroke Primary Prevention Trial (CSPPT). BMJ Open Diabetes Res. Care 2020, 8, e001423. [Google Scholar] [CrossRef]
  67. Duesing, K.; Charpentier, G.; Marre, M.; Tichet, J.; Hercberg, S.; Balkau, B.; Froguel, P.; Gibson, F. Evaluating the association of common APOA2 variants with type 2 diabetes. BMC Med. Genet. 2009, 10, 13. [Google Scholar]
  68. Castellani, L.W.; Goto, A.M.; Lusis, A.J. Studies with apolipoprotein A-II transgenic mice indicate a role for HDLs in adiposity and insulin resistance. Diabetes 2001, 50, 643–651. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  69. Rangwala, S.M.; Lazar, M.A. Peroxisome proliferator-activated receptor gamma in diabetes and metabolism. Trends Pharmacol. Sci. 2004, 25, 331–336. [Google Scholar] [CrossRef]
  70. Dumont, J.; Goumidi, L.; Grenier-Boley, B.; Cottel, D.; Marécaux, N.; Montaye, M.; Wagner, A.; Arveiler, D.; Simon, C.; Ferrières, J.; et al. Dietary linoleic acid interacts with FADS1 genetic variability to modulate HDL-cholesterol and obesity-related traits. Clin. Nutr. 2018, 37, 1683–1689. [Google Scholar] [CrossRef]
  71. Chen, Y.; Estampador, A.C.; Keller, M.; Poveda, A.; Dalla-Riva, J.; Johansson, I.; Renström, F.; Kurbasic, A.; Franks, P.W.; Varga, T.V. The combined effects of FADS gene variation and dietary fats in obesity-related traits in a population from the far north of Sweden: The GLACIER Study. Int. J. Obes. 2019, 43, 808–820. [Google Scholar] [CrossRef]
  72. Qi, L.; Zhang, C.; Greenberg, A.; Hu, F.B. Common variations in perilipin gene, central obesity, and risk of type 2 diabetes in US women. Obesity 2008, 16, 1061–1065. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  73. Yu, D.; Li, C.; Xie, J.; Xu, G.; Li, Y.; Liu, J.; Chen, B.; Pan, J.; Shen, M.; Yang, L.; et al. Association between three genetic variants of the Perilipin Gene (PLIN) and glucose metabolism: Results from a replication study among Chinese adults and a meta-analysis. Endocr. Res. 2013, 38, 263–279. [Google Scholar] [CrossRef]
  74. Ferguson, L.R.; De Caterina, R.; Görman, U.; Allayee, H.; Kohlmeier, M.; Prasad, C.; Choi, M.S.; Curi, R.; de Luis, D.A.; Gil, Á.; et al. Guide and Position of the International Society of Nutrigenetics/Nutrigenomics on Personalised Nutrition: Part 1Fields of Precision Nutrition. J. Nutr. Nutr. 2016, 9, 12–27. [Google Scholar] [CrossRef] [Green Version]
  75. Maria Catherine, B. Otero LFB: Role of Nutrigenomics in Modern-Day Healthcare and Drug Discovery; Elsevier: Amsterdam, The Netherlands, 2023. [Google Scholar]
Figure 1. PRISMA flowchart showing the selection of articles for this study based on inclusion and exclusion criteria.
Figure 1. PRISMA flowchart showing the selection of articles for this study based on inclusion and exclusion criteria.
Nutrients 15 02948 g001
Figure 2. Gene–diet interactions on obesity-related traits. The figure shows the significant gene–diet interactions (p < 0.05) on obesity traits and the dietary factors that have influenced the risk of obesity in individuals carrying specific genetic variations in the Malaysian [25], Indonesian [12,21,29,30,31,33] and Singaporean [34,35] populations. GRS, genetic risk score; BMI, body mass index; EPA + DHA, eicosapentaenoic acid + docosahexaenoic; TEI, total energy intake; plus-minus symbol (±) indicates Standard deviation.
Figure 2. Gene–diet interactions on obesity-related traits. The figure shows the significant gene–diet interactions (p < 0.05) on obesity traits and the dietary factors that have influenced the risk of obesity in individuals carrying specific genetic variations in the Malaysian [25], Indonesian [12,21,29,30,31,33] and Singaporean [34,35] populations. GRS, genetic risk score; BMI, body mass index; EPA + DHA, eicosapentaenoic acid + docosahexaenoic; TEI, total energy intake; plus-minus symbol (±) indicates Standard deviation.
Nutrients 15 02948 g002
Figure 3. Gene–diet interactions on diabetes-related traits. The figure shows the significant gene–diet interactions (p < 0.05) on diabetes traits and the dietary factors that influenced the risk of diabetes in individuals carrying specific genetic variations in the Malysian [39], Indonesian [32] and Singaporean [36,41] populations. GRS, genetic risk score; BMI, body mass index; SFA, saturated fatty acids; PUFA, polyunsaturated fatty acids; HOMA-IR, homeostatic model assessment—insulin resistance; TE, total energy.
Figure 3. Gene–diet interactions on diabetes-related traits. The figure shows the significant gene–diet interactions (p < 0.05) on diabetes traits and the dietary factors that influenced the risk of diabetes in individuals carrying specific genetic variations in the Malysian [39], Indonesian [32] and Singaporean [36,41] populations. GRS, genetic risk score; BMI, body mass index; SFA, saturated fatty acids; PUFA, polyunsaturated fatty acids; HOMA-IR, homeostatic model assessment—insulin resistance; TE, total energy.
Nutrients 15 02948 g003
Figure 4. Common genes involved in gene–diet interactions associated with obesity and diabetes in the Southeast Asian population (Malaysia, Indonesia, and Singapore). AGTR1, angiotensin II receptor type 1; AGTR2, angiotensin II receptor type 2; ADRB2, adrenoceptor beta 2; FADS1, fatty acid desaturase 1; FTO, fat mass and obesity-associated gene; VEGFR2, vascular endothelial growth factor receptor 2; APOA2, apolipoprotein A2; PPARg, peroxisome proliferator-activated receptor-gamma.
Figure 4. Common genes involved in gene–diet interactions associated with obesity and diabetes in the Southeast Asian population (Malaysia, Indonesia, and Singapore). AGTR1, angiotensin II receptor type 1; AGTR2, angiotensin II receptor type 2; ADRB2, adrenoceptor beta 2; FADS1, fatty acid desaturase 1; FTO, fat mass and obesity-associated gene; VEGFR2, vascular endothelial growth factor receptor 2; APOA2, apolipoprotein A2; PPARg, peroxisome proliferator-activated receptor-gamma.
Nutrients 15 02948 g004
Table 1. Summary table of gene–diet interactions on obesity in populations from Southeast Asians by country.
Table 1. Summary table of gene–diet interactions on obesity in populations from Southeast Asians by country.
GeneGenetic
Variation
Study Designn (Men/Women)EthnicityAge (Years)Dietary
Factors
OutcomesPinteractionInterpretationRef.
Malaysia
FADS1rs174547C-S 200
(69/131)
Chinese
Indians
>18Linoleic acid (7.9 ± 3.6 g/day)WC0.177No significant interaction;
vegetarians with TT genotype had higher odds of MetS, larger WC, and low HDL-c
[24]
α-Linolenic Aaid (0.4–0.8 g/day)0.258
Maternal VDRrs2228570C-S 217
(107/110)
Malay
Chinese
Indians
Kadazan
Bajau
Suluk
Mixed Ethnic
28.9 ± 4.2Maternal 25OHD (< or >30 nmol/L),
infant 25OHD (< or >30 nmol/L)
Infant birth weight0.018Significant interaction. Inverse association of maternal Vit D deficiency with neonatal birth anthropometry; neonatal G allele carriers associated with higher birth weight[25]
Maternal GCrs7041
Maternal GCrs4588
Cord VDRrs2228570
Cord GCrs7041
Cord GCrs4588
FTOrs9930501RCT103
(16/87)
Malay
Chinese
Indians
>18Hipcref (high-protein calorie-restricted) dietBMI0.125No significant interactions[26]
rs9930506Body weight0.058
rs9932754WC0.224
ADRB2rs1042713WHR0.369
Fat mass0.234
rs1042714BFP0.468
Muscle mass0.068
AGTR1rs5186C-S 507
(154/353)
Malay
Chinese
Indian
30–65Vegetables, fruits, soy diet (VFSD) in Malay BMI 0.994No significant interactions; Malay and Chinese showed high risk for lipids with gene–diet interactions but not Indians[27]
Rice, egg and fish diet (REFD) in Chinese0.66
AGTR2rs1403543VFSD in Chinese females0.053
VEGFR2Rs1870377P-C179Chinese30–65Meat, rice, and noodles dietBMI0.408No significant interactions[28]
Indonesia
UCP2rs659366
(−866G/A) AA + GA Genotype
P-C203Indonesian20–56Total energy intake (kcal)
[2570 ± 1066 (baseline) to 2120 ± 1042 (after 2 years)]
Changes in body weight (kg)0.263No significant interactions[29]
Changes in % body fat0.303
Changes in WHR0.464
Fat intake % [23.9 ± 11.2]Changes in body weight (kg)0.896
Changes in % body fat0.965
Changes in WHR0.996
Carbohydrate intake % [63.9 ± 11.2 (baseline) to 64.2 ± 10.4 (after 2 years)]Changes in body weight (kg) 0.433
Changes in % body fat0.839
Changes in WHR0.665
Protein intake % [12·3 ± 3.4 (baseline) to 12.4 ± 3.7 (after 2 years)]Changes in body weight (kg) 0.076
Changes in % body fat0.360
Changes in WHR0.355
Physical activity (MET-min/week)Changes in body weight (kg) 0.251
Changes in % body fat0.979
Changes in WHR0.684
UCP2rs659366
(−866G/A)
GG Genotype
P-C120Indonesian20–56Total energy intake (kcal)
[2570 ± 1066 (baseline) to 2120 ±1042 (after 2 years)]
Changes in body weight (kg) 0.016Significant interaction between UCP2 gene variation and total energy intake on body weight change and BFP

Significant interaction between UCP2 gene variation and physical activity on WHR
Changes in % body fat0.034
Changes in WHR0.070
Fat intake % [23.9 ±11.2]Changes in body weight (kg) 0.682
Changes in % body fat0.974
Changes in WHR0.753
Carbohydrate intake % [63.9 ± 11.2 (baseline) to 64.2 ±10.4 (after 2 years)]Changes in body weight (kg) 0.580
Changes in % body fat0.771
Changes in WHR0.826
Protein intake % [12·3 ± 3.4 (baseline) to 12.4 ± 3.7 (after 2 years)]Changes in body weight (kg) 0.830
Changes in % body fat0.913
Changes of WHR0.103
Physical activity (MET-min/week)Changes in body weight (kg) 0.666
Changes in % body fat0.653
Changes in WHR0.040
GRSVitamin D GRS [DHCR7, CYP2R1, CYP24A1, GC, CASR]C-S 110Minangkabau women25–60Carbohydrate [(235.2 g ± 73.5)] BFP0.049A significant interaction between Vitamin D GRS and carbohydrate intake on logBFP; carriers of more than 2 risk alleles and consumed high carbohydrate amounts had significantly high logBFP[12]
Metabolic GRS [FTO, TCF7L2, MC4R, KCNQ1, CDKN2A/B]Carbohydrate [(235.2 g ± 73.5)] and protein [77.87 g ± 220.5]BMI
WC
BFP
0.997No significant interactions
UCP2rs659366 (−866G/A)C-C261
(145/116)
Indonesian15–21Fat intake % [(>24.14 ± 5.95]Obesity0.006A significant interaction between UCP2 rs659366 (−866G/A) and fat intake on obesity[30]
UCP2rs659366 (−866 AA + GA)C-S 455
(223/232)
Indonesian19–56Coffee intake ml (34.5 ± 89.6)BMI0.214Significant interaction between UCP2 rs659366 (−866 AA + GA) and coffee intake on body fat[31]
Body fat0.015
WC0.302
Hip circumference0.253
rs659366 (−866 GG)Coffee intake ml (37.1 ± 106.4)BMI0.231
Body fat0.313
WC0.510
Hip circumference0.421
GRS9-SNP-B12-GRSC-S 117Minangkabau women25–60Fat (59.00 g ± 33.10)BMI0.933A significant interaction between B12 GRS and protein energy (%) on BFP [32]
WC0.444
BFP0.275
Carbohydrate (233 g ± 71)BMI0.685
WC0.875
BFP0.064
Protein energy (76.90 g ± 36.50)BMI0.993
WC0.395
BFP0.034
Fiber energy (8.80 g ± 4.50)BMI0.155
WC0.547
BFP0.697
9-SNP-Metabolic-GRSFat (59.00 g ± 33.10)BMI0.422A significant interaction between metabolic GRS and protein energy (%) on WC
WC0.812
BFP0.775
Carbohydrate ((233 g ± 71)BMI0.230
WC0.072
BFP0.844
Protein energy (76.90 g ± 36.50)BMI0.110
WC0.032
BFP0.568
Fiber energy (8.80 g ± 4.50)BMI0.273
WC0.648
BFP0.423
GRS6SNP-Vitamin D-GRS (≤3)P-C183Minangkabau women29.6 ± 5.56Maternal carbohydrate intake during third trimesterInfant birth weight0.611Significant interactions between VDR GRS and carbohydrate intake on new-born birth length

Pregnant women with a high genetic risk of vitamin D deficiency with high carbohydrate intake gave birth to babies with lower birth lengths
[33]
Infant birth length0.065
6SNP-Vitamin D-GRS (≥4)Infant birth weight0.872
Infant birth length0.073
4-SNP-GRS[DHCR7, GC, CYP24A1 and CYP2R1] (<3)Infant birth weight0.841
Infant birth length0.256
4-SNP-GRS[DHCR7, GC, CYP24A1 and CYP2R1] (≥3)Infant birth weight0.795
Infant birth length0.079
2-SNP-VDR-GRS (<2)Infant birth weight0.810
Infant birth length0.032
2-SNP-VDR-GRS (≥2)Infant birth weight0.775
Infant birth length0.099
GRS15-SNP-cardiometabolic disease related traits-GRSC-S110Minangkabau women25–60Carbohydrate (53.97 ± 9.44) BMI0.961Significant interaction between GRS and protein intake on obesity-related outcome[21]
WC0.224
Protein (13.51 ± 1.18% TEI) BMI0.282
WC0.002
Fat (28.95 ± 7.99)BMI0.721
WC0.577
BMI0.876
Fiber g (8.78 ± 4.29)WC 0.614
Singapore
CCDC171rs4740619C-S
P-C
7817Chinese24–95Cholesterol (lowest consumption group 184.35 ± 116.00 to highest consumption group 260.61 ± 150.56)BMI0.043Significant interaction was observed; CCDC171 rs4740619 interaction with cholesterol showed increased BMI level in subjects[34]
FADSrs174570P-C5264Chinese30–55Total fish (0.16 servings per day ±0.07)
Food sourced EPA + DHA (0.33 g/d ±0.20)
BMI0.035Significant interaction was observed.; long-term BMI changes in people with high fish/n-3 PUFA intake carrying signature allele show increased weight gain and risk of obesity [35]
APOA2rs5082(−265T > C)C-S 3605
(1714/1891)
Chinese
Malay
Indian
18–69SFA intake (22 g)BMI0.758No significant interactions[36]
PPAR-ϒrs1801282(Pro12Ala)C-S4038
(1869/2169)
Chinese
Malay
Indian
18–69PUFA/SFABMI0.873No significant interactions [37]
rs3856806(C1431T)0.472
Notes: Hipcref (high-protein calorie-restricted) Diet: energy deficit of 300–500 kcal/day, 30% energy from protein, 30% energy from fat, 40% energy from carbohydrate, vitamin E ≥ 15 mg/day, and fiber ≥ 25 g/day. Control diet: dietary advice on weight loss based on the Malaysian Dietary Guidelines 2010 (<1500 kcal/day with a macronutrient composition of approximately 10–15% energy from protein, 20–30% energy from fat, and 55–70% energy from carbohydrate) c PRS (polygenic risk score): FTO rs9930501, rs9930506, rs9932754 ADRB2 rs1042713, rs1042714. PRAL: potential renal acid load = 0.49 protein (g/day) + 0.037 phosphorus (mg/day)—0.021 potassium (mg/day)—0.026 magnesium (mg/day)—0.013 calcium (mg/day). C-S, cross-sectional; P-C, prospective-cohort study; RCT, randomized control trial. Statistically significant gene-diet interactions are highlighted in bold.
Table 2. Summary table of gene–diet interactions on diabetes in Southeast Asians by country.
Table 2. Summary table of gene–diet interactions on diabetes in Southeast Asians by country.
GenesGenetic
Variations
Study Designn
(Male/Female)
EthnicityAge
(Years)
Dietary
Factors
OutcomesPinteractionInterpretationRef.
Malaysia
FTOrs9930501RCT103
(16/87)
Malay
Chinese Indians
>18Hipcref a (high-protein calorie-restricted) control diet bFasting glucose 0.381Significant interaction observed;participants showed a greater reduction in hsCRP levels with the Hipcref diet compared to normal diet [26]
rs9930506Fasting insulin0.121
rs9932754
ADRB2rs1042713HOMA-IR0.122
rs1042714hs-CRP0.048
AGTR1rs5186C-S 507
(154/353)
Malay Chinese Indian30–65Vegetables, fruits, and soy diet (VFSD) in MalaysHbA1C0.537No significant interactions[27]
Rice, egg, and fish diet (REFD) in Chinese0.844
AGTR2rs1403543VFSD in Chinese females0.989
VEGFR2rs1870377C-S 179Chinese30–65Meat, rice, and noodles dietBlood glucosep > 0.05 No significant interactions[28]
HbA1cp > 0.05
FADS1rs174547C-S 200
(69/131)
Chinese Indians>18Linoleic acid (7.9 ± 3.6 g/day)Log FBG0.807No significant interactions[24]
α-Linolenic acid (0.4–0.8 g/day)0.293
IGF1rs35767C-S 211Chinese 66.7 ± 6DAL (using PRAL)FBGNSNo significant interactions; study shows association between DAL and high FBG, indicating a potential risk factor for diabetes[38]
IGF1rs7136446
IL6rs1800796
ADRB2rs1042713C-S 126Malaysian Chinese Indians18–74Saturated fat intake (<7.3% of total energy/day)
PUFA intake (≥0.8/day)
PUFA:SFA ratio (≥6% of TE/ day)
FBG0.011Significant gene diet interactions; G allele carriers of ADRB2 rs1042713 are associated with increased odds of insulin resistance [39]
HOMA-IR0.026
Fasting insulin0.036
Indonesia
GRS9-SNP-B12-GRSC-S 117Minangkabau women25–60Fat (59.00 ± 33.10)log HbA1c0.175Significant interaction between B12 GRS and fiber intake on HbA1c levels; individuals with ≥9 risk alleles who consumed low fiber diet had significantly higher HbA1c levels[32]
log FBG0.374
log fasting serum insulin0.757
Carbohydrate (233 ± 71)log HbA1c0.091
log FBG0.260
log fasting serum insulin0.341
Protein (76.90 ± 36.50) log HbA1c0.150
log FBG0.368
log fasting serum insulin0.073
Fiber intake (8.80 ± 4.50)log HbA1c0.042
log FBG0.380
log fasting serum insulin0.215
9-SNP-Metabolic-GRSFat (59.00 ± 33.10)log HbA1c0.298
log FBG0.634
log fasting serum insulin0.108
Carbohydrate (233 ± 71)log HbA1c0.166
log FBG0.771
log fasting serum insulin0.104
Protein (76.90 ± 36.50) log HbA1c0.155
log FBG0.929
log fasting serum insulin0.890
Fiber intake (g/d) (4.90 ± 1.00 g/day)log HbA1c0.851
log FBG0.215
log fasting serum insulin0.947
GRSMetabolic GRS [FTO, TCF7L2, MC4R, KCNQ1, CDKN2A/B]C-S 110Minangkabau women25–60Carbohydrate (g/d) (233.7 ± 75.1 g)Glucose0.360No significant interactions [12]
HbA1c0.780
Fasting insulin0.630
Protein (g/d) (77.2 ± 41.7 g)Glucose0.560
HbA1c0.680
Fasting insulin0.220
Fat (g/d) (61.2 ± 36.1 g)Glucose0.700
HbA1c0.780
Fasting insulin0.440
Fiber (g/d) (8.6 ± 4.3 g)Glucose0.830
HbA1c0.530
Fasting insulin0.440
GRS15-SNP-cardiometabolic disease related traits-GRSC-S110Minangkabau women25–60Carbohydrates % (53.97 ± 9.44)logGlucose0.882No significant interactions[21]
logInsulin0.336
logHbA1c0.766
Protein % (16.93 ± 3.32)logGlucose0.751
logInsulin0.341
logHbA1c0.638
Fat % (28.95 ± 7.99) logGlucose0.732
logInsulin0.480
logHbA1c0.935
Fiber g (8.78 ± 4.29)logGlucose0.833
logInsulin0.216
logHbA1c0.162
Singapore
GRSDM 37-SNP GRSP-C38,434Chinese30–79Alcohol (men: 10–25 g/d; women: 5–15 g/d)Diabetes riskNSNo significant interaction; but a healthy lifestyle and any genetic risk category was associated with a significantly lower risk of diabetes [40]
VFSD pattern
Meat—dim sum pattern
PLINrs894160(11482G > A)C-S 4107Chinese
Malay
Indian
18–69Total fat % (25.2–29.8 TEI)Fasting glucose 0.425Significant interaction between PLIN variants and dietary factors on diabetes related outcomes [41]
Fasting insulin0.01
HOMA-IR0.007
SFA % (9.4–11.8)Fasting glucose 0.004
Fasting insulin0.004
HOMA-IR0.003
Carbohydrates % (56.3–61.7)Fasting glucose 0.145
Fasting insulin0.007
HOMA-IR0.004
rs1052700(14995A > T)Total fat % (25.2–29.8 TEI)Fasting glucose 0.448
Fasting insulin0.014
HOMA-IR0.012
SFA % (9.4–11.8)Fasting glucose 0.009
Fasting insulin0.014
HOMA-IR0.005
Carbohydrates % (56.3–61.7)Fasting glucose 0.293
Fasting insulin0.008
HOMA-IR0.012
PPAR-ϒrs1801282(Pro12Ala)C-S4038
1869/2169)
Chinese
Malay
Indian
18–69PUFA/SFAInsulin0.089No significant interactions[37]
rs3856806(C1431T)0.175
APOA2rs5082(−265T > C)C-S 3605
(1714/1891)
Chinese
Malay
Indian
18–69SFA intake (22 g)HOMA-IR0.026Significant interaction between APOA2 rs5082(−265T > C) and SFA intake on HOMA-IR[36]
Notes. a Hipcref (high-protein calorie-restricted) Diet: energy deficit of 300–500 kcal/day, 30% energy from protein, 30% energy from fat, 40% energy from carbohydrate, vitamin E ≥15 mg/day, and fiber ≥25 g/day. b control diet: dietary advice on weight loss based on the Malaysian Dietary Guidelines 2010 (<1500 kcal/ day with a macronutrient composition of approximately 10–15% energy from protein, 20–30% energy from fat, and 55–70% energy from carbohydrate) c PRS: FTO rs9930501, rs9930506, rs9932754 ADRB2 rs1042713, rs1042714. PRAL: potential renal acid load = 0.49 protein (g/day) + 0.037 phosphorus (mg/day)—0.021 potassium (mg/day)—0.026 magnesium (mg/day)—0.013 calcium (mg/day). C-S, cross-sectional; P-C, prospective-cohort study; RCT, randomized control trial. Statistically significant gene-diet interactions are highlighted in bold.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Sekar, P.; Ventura, E.F.; Dhanapal, A.C.T.A.; Cheah, E.S.G.; Loganathan, A.; Quen, P.L.; Appukutty, M.; Taslim, N.A.; Hardinsyah, H.; Md Noh, M.F.; et al. Gene–Diet Interactions on Metabolic Disease-Related Outcomes in Southeast Asian Populations: A Systematic Review. Nutrients 2023, 15, 2948. https://doi.org/10.3390/nu15132948

AMA Style

Sekar P, Ventura EF, Dhanapal ACTA, Cheah ESG, Loganathan A, Quen PL, Appukutty M, Taslim NA, Hardinsyah H, Md Noh MF, et al. Gene–Diet Interactions on Metabolic Disease-Related Outcomes in Southeast Asian Populations: A Systematic Review. Nutrients. 2023; 15(13):2948. https://doi.org/10.3390/nu15132948

Chicago/Turabian Style

Sekar, Padmini, Eduard Flores Ventura, Anto Cordelia T. A. Dhanapal, Eddy Seong Guan Cheah, Annaletchumy Loganathan, Phoon Lee Quen, Mahenderan Appukutty, Nurpudji Astuti Taslim, Hardinsyah Hardinsyah, Mohd Fairulnizal Md Noh, and et al. 2023. "Gene–Diet Interactions on Metabolic Disease-Related Outcomes in Southeast Asian Populations: A Systematic Review" Nutrients 15, no. 13: 2948. https://doi.org/10.3390/nu15132948

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop